DNM2 Gene DI-CMTB NGS Genetic DNA Test
Comprehensive Genetic Testing for Neurological Disorders
The DNM2 Gene DI-CMTB NGS Genetic DNA Test represents a significant advancement in the diagnosis and management of inherited neurological conditions. This specialized genetic test focuses on identifying mutations in the DNM2 (Dynamin 2) gene, which plays a crucial role in maintaining the structural integrity and function of peripheral nerves. When mutations occur in this gene, they can lead to Dominant Intermediate Charcot-Marie-Tooth Disease Type B (DI-CMTB), a progressive neurological disorder affecting motor and sensory nerves.
What Does This Test Measure?
This comprehensive genetic analysis utilizes Next-Generation Sequencing (NGS) technology to examine the entire DNM2 gene for:
- Point mutations and single nucleotide variations
- Insertions and deletions in the genetic code
- Copy number variations affecting gene function
- Pathogenic variants associated with DI-CMTB
- Novel genetic changes that may impact neurological function
Who Should Consider This Test?
This genetic test is recommended for individuals experiencing:
- Progressive muscle weakness in hands and feet
- Foot deformities such as high arches or hammertoes
- Difficulty walking or frequent tripping
- Reduced sensation in extremities
- Family history of inherited neuropathies
- Unexplained neurological symptoms with genetic suspicion
- Children showing delayed motor development
Benefits of DNM2 Genetic Testing
- Accurate Diagnosis: Provides definitive identification of DI-CMTB
- Personalized Treatment: Enables targeted therapeutic approaches
- Family Planning: Offers crucial information for genetic counseling
- Early Intervention: Facilitates proactive management strategies
- Disease Progression Monitoring: Helps track neurological changes
- Research Contribution: Advances understanding of neurological genetics
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our team of certified genetic counselors and neurologists:
- Positive Result: Indicates the presence of a pathogenic DNM2 mutation associated with DI-CMTB
- Negative Result: Suggests no detectable mutation in the DNM2 gene
- Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact
- Carrier Status: Determines if you carry the mutation without showing symptoms
All results include comprehensive explanations and recommendations for next steps in your healthcare journey.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| DNM2 Gene DI-CMTB NGS Genetic DNA Test | $500 USD | $700 USD |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.
Pre-Test Requirements
Before scheduling your DNM2 genetic test, we recommend:
- Comprehensive clinical history documentation
- Genetic counseling session with our specialists
- Development of a detailed family pedigree chart
- Discussion of testing implications and potential outcomes
Take Control of Your Neurological Health
Don’t let uncertainty about your neurological symptoms affect your quality of life. The DNM2 Gene DI-CMTB NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. With results available in 3-4 weeks and comprehensive support throughout the process, you can take proactive steps toward managing your neurological health.
Ready to schedule your genetic test? Call our dedicated genetics team today at +1(267) 388-9828 or book your appointment online. Our genetic counselors are available to answer your questions and guide you through the testing process.
